Coalition Comments to FDA Requesting Sesame Labeling Compliance Date Clarification
ASTA signed onto FBIA coalition comments to the Food and Drug Administration (FDA) in April 2022, requesting that the FDA clarify that the compliance date under the Food Allergy Safety, Treatment, Education, and Research Act (FASTER) means that food products containing sesame must be labeled with a sesame allergen statement on or after January 1, 2021 and that products labeled before that do not need to be in compliance with the FASTER Act.
04/12/2022 at 5:15 am
0
Related Resources
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.
Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.